Insider filing · FTRE
Peter M Neupert
Director
profile →
Fortrea Holdings Inc.
FTRE · Healthcare · 7 filings in 24 months
ticker →
Peter M Neupert bought $407K of Fortrea (FTRE)
Executed Aug 8 2025, disclosed Aug 12 2025, 3 days later.
Value, as filed
$407K
62,500 sh across 2 lots
Executed
Aug 8 2025
the trade date, as filed
Disclosed
Aug 12 2025
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
+52.6%
+43.3% from execution
Over the 21 trading sessions from the disclosed entry session (Aug 11 2025), the stock returned +52.6% (delay-adjusted); from the execution session (Aug 8 2025), +43.3%. Derived: entry at the session's open, exit at the close 20 sessions later.
The filer
PNPeter M Neupert (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $3.1M of ADPT (124,690 sh across 3 lots, as filed), executed Aug 17.
The name
FTREHealthcare · Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pha…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→